Physician profile
Sandra Tomczyk
NPI 1932475118
$609.97
in general payments reported to CMS, 2019-2025
11 companies · $299 in 2025
The $299 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.72 · 2023: $249 · 2024: $47.39 · 2025: $299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $595.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $595.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $194.56 | 2025 | Trek, Peritx, Denali Vena Cava Filter |
| Inari Medical, INC. | $131.58 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cardiva Medical, INC. | $80.42 | 2023 | Cardiva Vascade 6/7f Vcs |
| Boston Scientific Corporation | $50.49 | 2025 | Icefx Cryoablation System, Obsidio |
| Siemens Medical Solutions USA, INC. | $36.87 | 2023 | Embozene, Varian Cryocare Touch System |
| Medtronic, INC. | $30.18 | 2025 | Abre |
| Teleflex LLC | $23.76 | 2025 | Chocolate |
| Cagent Vascular INC | $18.30 | 2024 | Serrantor |
| Chiesi USA, INC. | $14.72 | 2021 | |
| Abbott Laboratories | $14.65 | 2024 | Perclose Proglide |
| Becton, Dickinson and Company | $14.44 | 2024 | Denali Vena Cava Filter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Tomczyk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.